Riskpilot← Back to searchSign inGet full accessSHL Medical AB
ABActiveOrg 5565309696Augustendalsvägen 7Research and experimental development on natural sciences and engineering · NACE 7210Est. 199683 employees
Revenue 2024
SEK 143,9M
+5% vs 2023
EBITDA margin
4.4%
-5% vs 2023
Equity ratio
44.9%
Financial strength
Net profit 2024
SEK 4,7M
-8% vs 2023
| Revenue | SEK 143,9M | +5% |
| EBITDA | SEK 6,3M | -5% |
| Net profit | SEK 4,7M | -8% |
| Total assets | SEK 77,1M | +26% |
| Equity | SEK 34,6M | +16% |
| Employees | 83 | — |
Legal name
SHL Medical AB
Org number
5565309696
Legal form
Aktiebolag
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2 april 1996
Share capital
SEK 8 000 000
Employees
83 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget skall bedriva design och utveckling av medicin- tekniska produkter inom medicinbranschen ävensom idka därmed förenlig verksamhet.
Address
Augustendalsvägen 7
Phone
+4684621800
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 149 860 | 150 296 | 142 845 | 137 406 | 143 861 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 3 212 | 7 894 | 8 637 | 6 634 | 6 292 |
| Depreciation & amort. | −2 784 | −2 480 | −1 960 | −495 | −1 332 |
| EBIT | 428 | 5 414 | 6 677 | 6 139 | 4 960 |
| Net financials | 3 060 | −3 057 | −1 767 | 415 | 729 |
| Profit before tax | 3 487 | 3 749 | 5 801 | 6 554 | 5 689 |
| Tax | −947 | −1 022 | −1 354 | −1 463 | −980 |
| Net profit | 2 540 | 2 727 | 4 447 | 5 091 | 4 709 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 251 985 | 84 481 | 82 411 | 61 150 | 77 082 |
| Equity | 202 613 | 45 341 | 49 788 | 29 879 | 34 588 |
| Long-term debt | 14 531 | 0 | 0 | 0 | 0 |
| Short-term debt | 30 471 | 35 033 | 28 038 | 31 271 | 37 914 |
| Total debt | 45 002 | 35 033 | 28 038 | 31 271 | 37 914 |
EBITDA margin
4.4%
This company
15.8%
Market median
-72% vs market
20202024
Equity ratio
44.9%
This company
38.2%
Market median
+18% vs market
20202024
Return on equity
13.6%
This company
18.4%
Market median
+26% vs market
20202024
Net profit margin
3.3%
This company
8.1%
Market median
-59% vs market
20202024
Asset turnover
1.87×
This company
1.12×
Market median
+67% vs market
20202024
Debt / equity
1.23×
This company
0.62×
Market median
-98% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
KE Chief Executive Officer | Chief Executive Officer | 2022 |
AG Chief Auditor | Chief Auditor | 2021 |
| Former (1) | ||
PM Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Board of Directors | 2024 | |
| Former (3) | ||
| Chairman | 2021 – 2024 | |
| Board of Directors | 2021 – 2021 | |
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
SHL MEDICAL AG
SHL Medical AB (this company)Board members of SHL Medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Karin Elisabet Lindman | Chief Executive Officer | 0 companies |
| Per Martin Linse | Chief Executive Officer | 0 companies |
| Anna Gabriella Hermansson | Chief Auditor | 0 companies |
| Johan Ulrich Fässler | Chairman | 0 companies |
| Rob Weeden Irish | Chairman | 0 companies |
| Elin Maria Wallin | Board of Directors | 0 companies |
| Anders Fredrik Strömvall | Board of Directors | 0 companies |
| Markus Tomas Puusepp | Board of Directors | 0 companies |
| Paula Kristin Nielsen | Board of Directors | 0 companies |